Clinical Trial Update: Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a predefined fixed dose of Gonal-f Pen (follitropin alfa) for IVF, assessing safety and efficacy based on subject baseline c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Gonal-f Pen (follitropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Phase 4 | Status: COMPLETED | Results posted: 2018-03-30